相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prefrontal Cortex Transcriptomic Deconvolution Implicates Monocyte Infiltration in Parkinson's Disease
Sai Batchu
NEURODEGENERATIVE DISEASES (2021)
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease
Neus Rabaneda-Lombarte et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Validation of Induced Microglia-Like Cells (iMG Cells) for Future Studies of Brain Diseases
Atoshi Banerjee et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
The Human Hippocampus in Parkinson's Disease: An Integrative Stereological and Proteomic Study
Sandra Villar-Conde et al.
JOURNAL OF PARKINSONS DISEASE (2021)
CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein
Tony Valente et al.
CELL DEATH AND DIFFERENTIATION (2020)
CD200 maintains the region-specific phenotype of microglia in the midbrain and its role in Parkinson's disease
Le Wang et al.
GLIA (2020)
Microglia and Parkinson's disease: footprints to pathology
Ekaterina Lazdon et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
Identification of the CD200R1 promoter and the association of its polymorphisms with the risk of Parkinson's disease
S. Lin et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Microglia and astrocyte dysfunction in parkinson's disease
Tae-In Kam et al.
NEUROBIOLOGY OF DISEASE (2020)
Neuroinflammation and protein pathology in Parkinson's disease dementia
Antonina Kouli et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Jordi Galiano-Landeira et al.
BRAIN (2020)
Disease Progression-Dependent Expression of CD200R1 and CX3CR1 in Mouse Models of Parkinson's Disease
Le Wang et al.
AGING AND DISEASE (2020)
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Cai-Yun Liu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Role of the CD200-CD200R Axis During Homeostasis and Neuroinflammation
Gemma Manich et al.
NEUROSCIENCE (2019)
Truncated CD200 stimulates tumor immunity leading to fewer lung metastases in a novel Wistar rat metastasis model
Jun Kuwabara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Microglial Implication in Parkinson's Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?
Cynthia Lecours et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Monocytes, microglia, and CD200-CD200R1 signaling are essential in the transmission of inflammation from the periphery to the central nervous system
Xin Xie et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology
Douglas G. Walker et al.
NEUROBIOLOGY OF AGING (2017)
Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages
Tony Valente et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease
Sudhakar R. Subramaniam et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
A Truncated form of CD200 (CD200S) Expressed on Glioma Cells Prolonged Survival in a Rat Glioma Model by Induction of a Dendritic Cell-Like Phenotype in Tumor-Associated Macrophages
Kana Kobayashi et al.
NEOPLASIA (2016)
Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients
Ruben Fernandez-Santiago et al.
EMBO MOLECULAR MEDICINE (2015)
CD200+ and CD200- macrophages accumulated in ischemic lesions of rat brain: The two populations cannot be classified as either M1 or M2 macrophages
Shirabe Matsumoto et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease
Helene Hall et al.
BRAIN (2014)
Direct induction of ramified microglia-like cells from human monocytes: Dynamic microglial dysfunction in Nasu-Hakola disease
Masahiro Ohgidani et al.
SCIENTIFIC REPORTS (2014)
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease
S. Iannaccone et al.
PARKINSONISM & RELATED DISORDERS (2013)
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
Adriana Sanchez-Danes et al.
EMBO MOLECULAR MEDICINE (2012)
Efficient Generation of A9 Midbrain Dopaminergic Neurons by Lentiviral Delivery of LMX1A in Human Embryonic Stem Cells and Induced Pluripotent Stem Cells
A. Sanchez-Danes et al.
HUMAN GENE THERAPY (2012)
Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice
Yun-Hee Sung et al.
LIFE SCIENCES (2012)
Inflammation and Adaptive Immunity in Parkinson's Disease
R. Lee Mosley et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease
Shi Zhang et al.
JOURNAL OF NEUROINFLAMMATION (2011)
CD200R1 Agonist Attenuates Mechanisms of Chronic Disease in a Murine Model of Multiple Sclerosis
Yingru Liu et al.
JOURNAL OF NEUROSCIENCE (2010)
Altered Regulation of CD200 Receptor in Monocyte-Derived Macrophages from Individuals with Parkinson's Disease
Xiao-Guang Luo et al.
NEUROCHEMICAL RESEARCH (2010)
Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF
Zhiqi Chen et al.
NUCLEIC ACIDS RESEARCH (2010)
Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation
Douglas G. Walker et al.
EXPERIMENTAL NEUROLOGY (2009)
Distribution of the Immune Inhibitory Molecules CD200 and CD200R in the Normal Central Nervous System and Multiple Sclerosis Lesions Suggests Neuron-Glia and Glia-Glia Interactions
Nathalie Koning et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
The influence of microglia on the pathogenesis of Parkinson's disease
Caitriona M. Long-Smith et al.
PROGRESS IN NEUROBIOLOGY (2009)
CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing
Sven G. Meuth et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Identification of an Expressed Truncated Form of CD200, CD200tr, Which is a Physiologic Antagonist of CD200-Induced Suppression
Zhiqi Chen et al.
TRANSPLANTATION (2008)
Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions
Nathalie Koning et al.
ANNALS OF NEUROLOGY (2007)
Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration
Tanuja Chitnis et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
Emilie Croisier et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Inflammatory process in Parkinson's disease: Role for cytokines
T Nagatsu et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains
K Imamura et al.
ACTA NEUROPATHOLOGICA (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Down-regulation of the macrophage lineage through interaction with OX2 (CD200)
RM Hoek et al.
SCIENCE (2000)
Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function
GJ Wright et al.
IMMUNITY (2000)